Clinical Trial Update: Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

This update reports on a completed Phase 1/2 trial evaluating Zosuquidar in combination with daunorubicin and cytarabine in adults aged 55-75 with newly diagnos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Zosuquidar (zosuquidar)

Snippet

Sponsor: Kanisa Pharmaceuticals | Conditions: Leukemia, Myeloid | Phase 1, Phase 2 | Status: COMPLETED